drugset / Trial / NCT04205565

Study on Clinical Effectiveness of L-Oxiracetam Injection

NCT04205565 ↗

Phase 3 Unknown 591 enrolled Nanjing Yoko Biomedical Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

A randomized, double-blind, positive drug/placebo parallel controlled, multicenter, phase III clinical trial of L-oxiracetam injection to improve memory and cognitive Impairment in patients with craniocerebral injury.

Timeline

Start
2019-09-30
Primary completion
2024-08-30
Completion
2024-10-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator L-oxiracetam Unknown 4 g Intravenous
Comparator Oxiracetam Small molecule 6 g Intravenous

Indications